Equities

Kairos Pharma Ltd

Kairos Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.50
  • Today's Change0.04 / 2.74%
  • Shares traded248.67k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 01:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Kairos Pharma Ltd fell by 344.00k. However, the company earned 81.00k from its operations for a Cash Flow Margin of --. In addition the company used on investing activities and also paid 425.00k in financing cash flows.
Cash flow per share-0.0815
Price/Cash flow per share--
Book value per share0.2594
Tangible book value per share0.239
More ▼

Balance sheet in USDView more

Kairos Pharma Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 4.09%.
Current ratio2.84
Quick ratio--
Total debt/total equity0.0426
Total debt/total capital0.0409
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.